Novarex Co

Novarex Co ROCE

The Return on Capital Employed (ROCE) of Novarex Co (194700.KQ) as of Nov 6, 2026 is 17.64 %. In the previous year, Return on Capital Employed (ROCE) was 13.55 % — a change of 30.21% (higher).

ROCE

17.64 %

YoY

30.21%

Last updated:

In 2025, Novarex Co's return on capital employed (ROCE) was 17.64 %, a 30.21% increase from the 13.55 % ROCE in the previous year.

The Novarex Co ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2017
19.10 KRW
Jan 1, 2018
14.03 KRW
Jan 1, 2019
17.76 KRW
Jan 1, 2020
23.35 KRW
Jan 1, 2021
22.47 KRW
Jan 1, 2022
13.80 KRW
Jan 1, 2023
13.55 KRW
Jan 1, 2025
17.64 KRW
The Novarex Co ROCE history
YEARROCEYoY
17.64 %+30.21%
13.55 %-1.81%
13.80 %-38.58%
22.47 %-3.78%
23.35 %+31.43%
17.76 %+26.60%
14.03 %-26.53%
19.10 %-17.05%
23.03 %-25.46%
30.89 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novarex Co Stock analysis

What does Novarex Co do? Novarex Co Ltd manufactures and sells dietary supplements including vitamin and mineral products, body fat reduction solutions, eye health aids, joint health products, lactic acid bacteria for skin improvement, coenzyme Q10, wild mango seed extract, and spirulina. The company distributes these products domestically in Korea and internationally. Its primary customers are consumers seeking health functional foods and nutritional supplements. The firm focuses on branded products that target specific health concerns such as body fat, eye health, and joint care. Novarex Co Ltd's revenue streams come from the sale of its diverse supplement portfolio to both domestic and international markets. The company's product range includes individual recognition products designed for specific health benefits, alongside general nutritional supplements. Sales are driven by consumer demand for health-focused functional foods and dietary supplements in the Korean market and overseas. The company's manufacturing and distribution operations support its product lines, which include specialized items like wild mango seed extract and spirulina. These products cater to health-conscious consumers looking for natural solutions for body fat reduction, eye health, and skin conditions. Novarex Co Ltd's business model relies on direct sales of branded supplements to end consumers through domestic and international channels. Novarex Co is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Novarex Co's Return on Capital Employed (ROCE)

Novarex Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Novarex Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Novarex Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Novarex Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Novarex Co stock

Return on Capital Employed (ROCE) of Novarex Co is 17.64 % in 2025.

Return on Capital Employed (ROCE) of Novarex Co changed from 13.55 % to 17.64 %, representing a 30.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Novarex Co since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Novarex Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Novarex Co

All Key Metrics — Novarex Co